RE:RE:RE:New weapon against refractory cancersIt may be a long shot but it is worth a try and could be successful if handled correctly. TH would need to spend money on a professional PR firm who would know best how to position the story with the press. First you get it in some medical press and then you can potentially leverage that coverage into broader coverage in the business and general press. The headline should be something like "Is a tiny Canadian company on the cusp of a major breakthrough in defeating cancer?" The TH 1902 story is intriguing and compelling. It might be a story that the press would run with.
jfm1330 wrote: These big medias won't do an article about a pre-clinical cancer drug. Comparing these with the UQAM little news bulletin is not right.
Wino115 wrote: THIS is why they need to call business press, magazines and pitch the story. It will be taken up. This is obviously the Montreal connections, but US business press is also always looking for stories like this. I hope the PR side, either Leah or the guy who starts the CC's, calls AP, UPI, Bloomberg, WSJ, NYT Science staff, Stat News, etc... and pitches this complelling story.